The Smoking Paradox: Impact of Smoking on Recanalization in the Setting of Intra-Arterial Thrombolysis
暂无分享,去创建一个
G. Sirimarco | P. Amarenco | I. Klein | M. Mazighi | J. Labreuche | E. Meseguer | J. González-Valcárcel | P. Lavallée | L. Cabrejo | C. Guidoux | Philippa C. Lavallée
[1] G. Luijckx,et al. Letter by Plas et al regarding article, "smoking-thrombolysis paradox: recanalization and reperfusion rates after intravenous tissue plasminogen activator in smokers with ischemic stroke". , 2013, Stroke.
[2] M. Endres,et al. Smoking-Thrombolysis Paradox: Recanalization and Reperfusion Rates After Intravenous Tissue Plasminogen Activator in Smokers With Ischemic Stroke , 2013, Stroke.
[3] J. Olivot,et al. Outcomes after thrombolysis in AIS according to prior statin use , 2012, Neurology.
[4] Gerhard Schroth,et al. Endovascular Therapy of 623 Patients With Anterior Circulation Stroke , 2012, Stroke.
[5] D. Leys,et al. Influence of Differences in Case Mix on the Better Outcome of Smokers after Intravenous Thrombolysis for Acute Cerebral Ischemia , 2012, European Neurology.
[6] J. Serfaty,et al. Impact of a Combined Intravenous/ Intra-Arterial Approach in Octogenarians , 2011, Cerebrovascular Diseases.
[7] A. Wolberg,et al. Plasma and cellular contributions to fibrin network formation, structure and stability , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.
[8] A. Słowik,et al. Fibrin clot properties in acute ischemic stroke: relation to neurological deficit. , 2010, Thrombosis research.
[9] D. Margosan,et al. Effects of Cigarette Smoke Exposure on Clot Dynamics and Fibrin Structure: An Ex Vivo Investigation , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[10] R. Topor-Madry,et al. Effect of cigarette smoking on plasma fibrin clot permeability and susceptibility to lysis , 2009, Thrombosis and Haemostasis.
[11] J. De Keyser,et al. Does smoking influence outcome after intravenous thrombolysis for acute ischaemic stroke? , 2009, European journal of neurology.
[12] D. Grönemeyer,et al. Smoking cessation and subclinical atherosclerosis--results from the Heinz Nixdorf Recall Study. , 2009, Atherosclerosis.
[13] Gary A. Ford,et al. Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) , 2008, Stroke.
[14] M. Fisher. The smoking–thrombolysis paradox and acute ischemic stroke , 2006, Neurology.
[15] A. Tenenbaum,et al. Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. , 2003, Archives of internal medicine.
[16] M. McNurlan,et al. Effects of smoking and abstention from smoking on fibrinogen synthesis in humans. , 2001, Clinical science.
[17] M. Kaste,et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.
[18] S M Grundy,et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. , 1998, Circulation.
[19] S. Grundy,et al. Primary Prevention of Coronary Heart Disease: Guidance From Framingham A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction , 1998 .
[20] P Trouillas,et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. , 1998, Lancet.
[21] M. Kaste,et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.
[22] R. Diaz,et al. Significance of Smoking in Patients Receiving Thrombolytic Therapy for Acute Myocardial Infarction Experience Gleaned From the International Tissue Plasminogen Activator/Streptokinase Mortality Trial , 1993, Circulation.
[23] M. Kaste,et al. The European Cooperative Acute Stroke Study (ECASS) , 1993 .
[24] A. Dobson,et al. How soon after quitting smoking does risk of heart attack decline? , 1991, Journal of clinical epidemiology.
[25] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.